Answers are grounded in this paper and cite their sources.
These data demonstrate that fenfluramine can significantly reduce day-to-day seizure burden in patients with DS, providing prolonged periods of convulsive seizure-free days, which may help reduce the physical and emotional disease toll while improving health-related QOL for patients and caregivers.
No takes yet. Share an insight, caveat, or question.
Sullivan et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: